Stone House Investment Management, LLC Altimmune, Inc. Transaction History
Stone House Investment Management, LLC
- $380 Million
- Q2 2024
A detailed history of Stone House Investment Management, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Stone House Investment Management, LLC holds 500 shares of ALT stock, worth $3,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$3,115
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
192Shares Held
42.2MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$33.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$30.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$24.4 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$20.1 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$17.1 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $305M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...